Cell surface biomarkers of embryonic stem cells

Proteomics

Volumn 8, Issue 19, 2008, Pages 4025-4035

  Nagano, Kohji ^a   Yoshida, Yoko ^b   Isobe, Toshiaki ^b,c  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b TOKYO METROPOLITAN UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cell surface biomarker; Embryonic stem cell; Glycoproteomics

Indexed keywords

ALKALINE PHOSPHATASE; CARBOHYDRATE; CELL SURFACE MARKER; CELL SURFACE PROTEIN; GLYCOLIPID; KERATAN SULFATE; PROTEOGLYCAN; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4;

CELL DIFFERENTIATION; CELL POPULATION; CELL SURFACE; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; FUNCTIONAL PROTEOMICS; GENOME ANALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; EMBRYONIC STEM CELLS; GENOMICS; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PROTEOMICS;

EID: 55749095513     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800073     Document Type: Review

References (64)

1. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
2. Biswas, A., Hutchins, R., Embryonic stem cells. Stem Cells Dev. 2007, 16, 213-222.
3. Hoffman, L. M., Carpenter, M. K., Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 2005, 23, 699-708.
4. Carpenter, M. K., Rosler, E., Rao, M. S., Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003, 5, 79-88.
5. Levenberg, S., Zoldan, J., Basevitch, Y., Langer, R., Endothelial potential of human embryonic stem cells. Blood 2007, 110, 806-814.
6. Wang, Z. Z., Au, P., Chen, T., Shao, Y. et al., Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 2007, 25, 317-318.
7. Barberi, T., Bradbury, M., Dincer, Z., Panagiotakos, G. et al., Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat. Med. 2007, 13, 642-648.
8. Roy, N. S., Cleren, C., Singh, S. K., Yang, L. et al., Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12, 1259-1268.
9. D'Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G. et al., Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24, 1392-1401.
10. Lu, S. J., Feng, Q., Caballero, S., Chen, Y. et al., Generation of functional hemangioblasts from human embryonic stem cells. Nat. Methods 2007, 4, 501-509.
11. Soto-Gutiérrez, A., Navarro-Alvarez, N., Zhao, D., Rivas-Carrillo, J. D. et al., Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat. Protoc. 2007, 2, 347-356.
12. Gouon-Evans, V., Boussemart, L., Gadue, P., Nierhoff, D. et al., BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat. Biotechnol. 2006, 24, 1402-1411.
13. Schroeder, I. S., Rolletschek, A., Blyszczuk, P., Kania, G., Wobus, A. M., Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat. Protoc. 2006, 1, 495-507.
14. Salero, E., Hatten, M. E., Differentiation of ES cells into cerebellar neurons. Proc. Natl. Acad. Sci. USA 2007, 104, 2997-3002.
15. West, J. A., Park, I. H., Daley, G. Q., Geijsen, N., In vitro generation of germ cells from murine embryonic stem cells. Nat. Protoc. 2006, 1, 2026-2036.
16. Baker, D. E., Harrison, N. J., Maltby, E., Smith, K. et al., Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25, 207-215.
17. Thomson, H., Bioprocessing of embryonic stem cells for drug discovery. Trends Biotechnol. 2007, 25, 224-230.
18. Yang, X., Smith, S. L., Tian, X. C., Lewin, H. A. et al., Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 2007, 39, 295-302.
19. Kim, K., Lerou, P., Yabuuchi, A., Lengerke, C. et al., Histocompatible embryonic stem cells by parthenogenesis. Science 2007, 315, 482-486.
20. Menendez, P., Bueno, C., Wang, L., Bhatia, M., Human embryonic stem cells: Potential tool for achieving immunotolerance? Stem Cell Rev. 2005, 1, 151-158.
21. Takahashi, K, Yamanaka, S., Induction of pluripotent stem cells frommouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
22. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
23. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J. et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
24. Pera, M. F., Reubinoff, B., Trounson, A., Human embryonic stem cells. J. Cell Sci. 2000, 113, 5-10.
25. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M. et al., Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. International Stem Cell Initiative. Nat. Biotechnol. 2007, 25, 803-816.
26. Brimble, S. N., Sherrer, E. S., Uhl, E. W., Wang, E. et al., The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 2007, 25, 54-62.
27. Evans, M. J., Kaufman, M. H., Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154-156.
28. Martin, G. R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78, 7634-7638.
29. Ginis, I., Luo, Y., Miura, T., Thies, S. et al., Differences between human and mouse embryonic stem cells. Dev. Biol. 2004, 269, 360-380.
30. Noggle, S. A., James, D., Brivanlou, A. H., A molecular basis for human embryonic stem cell pluripotency. Stem Cell Rev. 2005, 1, 111-118.
31. Boiani, M., Schöler, H. R., Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 2005, 6, 872-884.
32. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P. et al., Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448, 191-195.
33. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J. et al., New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448, 196-199.
34. Stewart, M. H., Bossé, M., Chadwick, K., Menendez, P. et al., Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat. Methods 2006, 3, 807-815.
35. Laursen, S. B., Møllgård, K., Olesen, C., Oliveri, R. S. et al., Regional differences in expression of specific markers for human embryonic stem cells. Reprod. Biomed. Online 2007, 15, 89-98.
36. Nunomura, K., Nagano, K., Itagaki, C., Taoka, M. et al., Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol. Cell. Proteomics 2005, 4, 1968-1976.
37. Park, H. W., Shin, J. S., Kim, C. W., Proteome of mesenchymal stem cells. Proteomics 2007, 7, 2881-2894.
38. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Yilmaz, O. H. et al., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121, 1109-1121.
39. Wagers, A. J., Stem cell grand SLAM. Cell 2005, 121, 967-970.
40. Stanton, L. W., Bakre, M. M., Genomic and proteomic characterization of embryonic stem cells. Curr. Opin. Chem. Biol. 2007, 11, 399-404.
41. Assou, S., Le Carrour, T., Tondeur, S., Ström, S. et al., A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007, 25, 961-973.
42. Ivanova, N., Dobrin, R., Lu, R., Kotenko, I. et al., Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 442, 533-538.
43. Lim, L. S., Loh, Y. H., Zhang, W., Li, Y. et al., Zic3 is required for maintenance of pluripotency in embryonic stem cells. Mol. Biol. Cell 2007, 18, 1348-1358.
44. Zhang, J., Tam, W. L., Tong, G. Q., Wu, Q. et al., Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 2006, 8, 1114-1123.
45. Ding, L., Buchholz, F., RNAi in embryonic stem cells. Stem Cell Rev. 2006, 2, 11-18.
46. Nagano, K., Taoka, M., Yamauchi, Y., Itagaki, C. et al., Largescale identification of proteins expressed in mouse embryonic stem cells. Proteomics 2005, 5, 1346-1361.
47. Van Hoof, D., Passier, R., Ward-Van Oostwaard, D., Pinkse, M. W. et al., A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 2006, 5, 1261-1273.
48. Rabilloud, T., Membrane proteins ride shotgun. Nat. Biotechnol. 2003, 21, 508-510.
49. Pasquali, C., Fialka, I., Huber, L. A., Subcellular fractionation, electromigration analysis and mapping of organelles. Chromatogr. B Biomed. Sci. Appl. 1999, 722, 89-102.
50. Durr, E., Yu, J., Krasinska, K. M., Carver, L. A. et al., Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 2004, 22, 985-992.
51. Blau, H. M., Brazelton, T. R., Weimann, J. M., The evolving concept of a stem cell: Entity or function. Cell 2001, 105, 829-841.
52. Graumann, J., Hubner, N. C., Kim, J. B., Ko, K. et al., SILAC-labeling and proteome quantitation of mouse embryonic stem cells to a depth of 5111 proteins. Mol. Cell. Proteomics 2008, 7, 672-683.
53. 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
54. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
55. Lee, M. S., Kerns, E. H., LC/MS applications in drug development. Mass Spectrom. Rev. 1999, 18, 187-279.
56. Keshishian, H., Addona, T., Burgess, M., Kuhn, E., Carr, S. A., Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2229.
57. Lanctot, P. M., Gage, F. H., Varki, A. P., The glycans of stem cells. Curr. Opin. Chem. Biol. 2007, 11, 373-380.
58. Yanagisawa, M., Yu, R. K., The expression and functions of glycoconjugates in neural stem cells. Glycobiology 2007, 17, 57R-74R.
59. Zhang, H., Li, XJ., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
60. Kaji, H., Yamauchi, Y., Takahashi, N., Isobe, T., Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging. Nat. Protoc. 2006, 1, 3019-3027.
61. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T. et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
62. Kaji, H., Kamiie, J., Kawakami, H., Kido, K. et al., Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis elegans and suggests an atypical translocation mechanism for integral membrane proteins. Mol. Cell. Proteomics 2007, 6, 2100-2109.
63. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K. et al., High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 2007, 6, 1809-1817.
64. Mirzaei, H., McBee, J., Watts, J., Aebersold, R., Comparative evaluation of current peptide production platforms used in absolute quantitation in proteomics. Mol. Cell. Proteomics 2008, 7, 813-823.